118163 ⎘
Intramolecular oxidoreductases (5.3) transposing C=C bonds (5.3.3) L-Dopachrome isomerase (5.3.3.12)
NOVEL NUCLEIC ACID MOLECULES
#2Nucleic acid molecules
#3Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
#4METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR
#5MHC-independent tumor-associated antigens
#6CHARACTERIZATION OF CHO-MIF GENE AND PROTEIN, AND USE THEREOF
#7Compositions and Methods for Diagnosing and Treating Diseases and Disorders Associated With D-DT
#8METHOD OF INHIBITING BINDING OR ACTIVITY OF MIF BY ADMINISTERING A MIF ANTAGONIST
#9T cell receptors with MHC independent binding to GM-CSF receptor alpha chain
#10Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
#11METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR
#12Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#13MIF antagonists
#14Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#15Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment
#16Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
#17Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
#18Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor